dalteparin ^Turanci (Q1851701)

Daga Wikidata

Jump to navigation Jump to search

pharmaceutical drug ^Turanci

Language	Label	Description	Also known as
Hausa	Ba suna a kai	Ba'a bayyana ma'ana ba
Turanci	dalteparin	pharmaceutical drug	Heparin Fragment KABI 2165 Tedelparin Fragmin

Statements

mixture ^Turanci

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

harshen aiki ko suna

Dalteparin (Turanci)

17 Nuwamba 2015

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

harshen aiki ko suna

Dalteparin (Turanci)

17 Nuwamba 2015

low molecular weight heparin ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

27 Faburairu 2018

medical condition treated ^Turanci

unstable angina ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

thrombophlebitis ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

postoperative complications ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

pulmonary embolism ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

significant drug interaction ^Turanci

enoxaparin ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tinzaparin ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rac-warfarin ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fondaparinux ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

heparin ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

acenocoumarol ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

phenindione ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

urokinase ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

alteplase ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenecteplase ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Streptokinase ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rivaroxaban ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

apixaban ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clopidogrel ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eptifibatide ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

iloprost ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tirofiban ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

prasugrel ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ticagrelor ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nabumetone ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

naproxen ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

celecoxib ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Diclofenac ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

piroxicam ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

meloxicam ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-fenoprofen ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(+-)-flurbiprofen ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ibuprofen ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indomethacin ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-ketoprofen ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-etodolac ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sulindac ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

parecoxib ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aceclofenac ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenoxicam ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

abciximab ^Turanci

matsalar da zata iya haifarwa

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

nabumetone ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

naproxen ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

celecoxib ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Diclofenac ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

piroxicam ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

meloxicam ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-fenoprofen ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(+-)-flurbiprofen ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ibuprofen ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indomethacin ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-ketoprofen ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-etodolac ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sulindac ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

enoxaparin ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tinzaparin ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

heparin ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

parecoxib ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

aceclofenac ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

tenoxicam ^Turanci

matsalar da zata iya haifarwa

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

Serpin family C member 1 ^Turanci

subject has role ^Turanci

activation ^Turanci

1 reference

stated in ^Turanci

Open Targets Platform ^Turanci

retrieved ^Turanci

14 Agusta 2023

adireshin manazarta

https://platform.opentargets.org/drug/CHEMBL1201460

pregnancy category ^Turanci

Australian pregnancy category C ^Turanci

1 reference

English Wikipedia ^Turanci

US pregnancy category B ^Turanci

1 reference

English Wikipedia ^Turanci

manufacturer ^Turanci

1 reference

adireshin manazarta

https://www.pfizer.com/products/product-list

subject has role ^Turanci

enzyme activator ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

antithrombin ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

serine proteinase inhibitor ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

anticoagulant ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

fibrinolytic agents ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

different from ^Turanci

dalteparin sodium ^Turanci

0 references

Identifiers

ChEMBL ID ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

retrieved ^Turanci

8 Faburairu 2021

EC number ^Turanci

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

retrieved ^Turanci

27 Disamba 2018

(3S,5S,6S)-3-{[(2S,3S,5R)-5-{[(2S,3S,5S)-6-carboxy-5-{[(2S,3S,5S)-4,5-dihydroxy-3-(sulfoamino)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]methoxy}-3-(sulfoamino)-4-(sulfooxy)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-6-({[(3S,5S,6S)-4,6-dihydroxy-5-(sulfoamino)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}methyl)-4-hydroxy-5-(sulfooxy)oxane-2-carboxylic acid (Turanci)

quotation ^Turanci

CAS no.: 9041-08-1 (Turanci)

ECHA Substance Infocard ID ^Turanci

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

retrieved ^Turanci

20 Disamba 2018

(3S,5S,6S)-3-{[(2S,3S,5R)-5-{[(2S,3S,5S)-6-carboxy-5-{[(2S,3S,5S)-4,5-dihydroxy-3-(sulfoamino)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]methoxy}-3-(sulfoamino)-4-(sulfooxy)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-6-({[(3S,5S,6S)-4,6-dihydroxy-5-(sulfoamino)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}methyl)-4-hydroxy-5-(sulfooxy)oxane-2-carboxylic acid (Turanci)

quotation ^Turanci

CAS no.: 9041-08-1 (Turanci)

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

harshen aiki ko suna

Dalteparin (Turanci)

17 Nuwamba 2015

Guide to Pharmacology Ligand ID ^Turanci

0 references

MeSH descriptor ID ^Turanci

subject named as ^Turanci

Dalteparin

0 references

Lambar itace MeSH

D09.698.373.400.300.150

0 references

RxNorm ID ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

26 Faburairu 2018

DrugBank ID ^Turanci

0 references

UNII ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

DALTEPARIN (Turanci)

retrieved ^Turanci

19 Janairu 2016

MedlinePlus drug identifier ^Turanci

0 references

PatientsLikeMe treatment ID ^Turanci

0 references

NDF-RT ID ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

DALTEPARIN (Turanci)

retrieved ^Turanci

19 Janairu 2016

KEGG ID ^Turanci

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

harshen aiki ko suna

Dalteparin (Turanci)

17 Nuwamba 2015

DeCS ID ^Turanci

0 references

electronic Essential Medicines List medicine ID ^Turanci

0 references

Freebase ID ^Turanci

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

28 Oktoba 2013

KBpedia ID ^Turanci

1 reference

stated in ^Turanci

KBpedia ^Turanci

retrieved ^Turanci

9 Yuli 2020

Microsoft Academic ID ^Turanci

0 references

UK Parliament thesaurus ID ^Turanci

subject named as ^Turanci

Dalteparin

0 references

UNSPSC Code ^Turanci

0 references

WikiProjectMed ID ^Turanci

0 references

Sitelinks

Wikipedia(19 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Wasu shafuka(0 entries)

Daga "https://www.wikidata.org/w/index.php?title=Q1851701&oldid=2190020590"